Wellington Management Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Wellington Management Group's MIRM Position: Q3 2026 in Review
Wellington Management Group increased its Mirum Pharmaceuticals (MIRM) stake by 29% in Q3 2026, buying an estimated $39.5M and bringing the position to 1,688,453 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #445.
Wellington Management Group first reported a position in MIRM in Q4 2020 and has held it in 21 quarters since. The position peaked at $153M in Q2 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Wellington Management Group held 1,688,453 shares of Mirum Pharmaceuticals worth $144M as of Q3 2026.
- Wellington Management Group bought 378,466 Mirum Pharmaceuticals shares in Q3 2026, an estimated $39.5M.
- Mirum Pharmaceuticals made up 0.03% of Wellington Management Group's portfolio in Q3 2026, its #445 holding.
- Wellington Management Group first reported a position in Mirum Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
- Wellington Management Group's Mirum Pharmaceuticals position peaked at $153M in Q2 2026.
- 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.